https://aldosteroneyang.com/mermaid-diagram-extension-chatgpt 2025-04-04T05:22:16.425Z daily 0.8 https://aldosteroneyang.com/ct-free-attenuation-and-monte-carlo-based-scatter-correction-guided-quantitative-90y-spect-imaging-for-improved-dose-calculation-using-deep-learning 2025-03-13T16:47:52.718Z daily 0.8 https://aldosteroneyang.com/article-review-ct-free-attenuation-and-monte-carlo-based-scatter-correction-guided-quantitative-90y-spect-imaging-for-improved-dose-calculation-using-deep-learning 2025-03-13T16:47:52.075Z daily 0.8 https://aldosteroneyang.com/feasibility-of-a-single-day-protocol-for-spect-and-pet-assessment-of-dopamine-transporter-availability-cardiac-innervation-and-metabolic-patterns-in-patients-with-movement-disorders 2025-03-12T16:49:33.170Z daily 0.8 https://aldosteroneyang.com/article-review-feasibility-of-a-single-day-protocol-for-spect-and-pet-assessment-of-dopamine-transporter-availability-cardiac-innervation-and-metabolic-patterns-in-patients-with-movement-disorders 2025-03-12T16:49:32.555Z daily 0.8 https://aldosteroneyang.com/a-cost-effectiveness-study-of-psma-pet-ct-for-the-detection-of-clinically-significant-prostate-cancer 2025-03-12T16:48:51.955Z daily 0.8 https://aldosteroneyang.com/article-review-a-cost-effectiveness-study-of-psma-pet-ct-for-the-detection-of-clinically-significant-prostate-cancer 2025-03-12T16:48:51.408Z daily 0.8 https://aldosteroneyang.com/impact-of-deep-learning-denoising-on-kinetic-modelling-for-low-dose-dynamic-pet-application-to-single-and-dual-tracer-imaging-protocols 2025-03-12T16:48:15.526Z daily 0.8 https://aldosteroneyang.com/article-review-impact-of-deep-learning-denoising-on-kinetic-modelling-for-low-dose-dynamic-pet-application-to-single-and-dual-tracer-imaging-protocols 2025-03-12T16:48:14.836Z daily 0.8 https://aldosteroneyang.com/alternative-treatment-for-recurrent-keloids-initial-clinical-experience-with-rhenium-188-using-a-specialized-device 2025-03-12T16:47:21.314Z daily 0.8 https://aldosteroneyang.com/article-review-alternative-treatment-for-recurrent-keloids-initial-clinical-experience-with-rhenium-188-using-a-specialized-device 2025-03-12T16:47:20.904Z daily 0.8 https://aldosteroneyang.com/impact-of-extended-177lu-lu-psma-617-therapy-on-absorbed-kidney-dose-and-ckd-epi-values-how-long-can-therapy-be-safely-continued 2025-03-10T16:47:21.463Z daily 0.8 https://aldosteroneyang.com/article-review-impact-of-extended-177lu-lu-psma-617-therapy-on-absorbed-kidney-dose-and-ckd-epi-values-how-long-can-therapy-be-safely-continued 2025-03-10T16:47:20.477Z daily 0.8 https://aldosteroneyang.com/podcast-episode-347-the-case-for-index-funds-rational-reminder 2025-03-08T16:49:09.782Z daily 0.8 https://aldosteroneyang.com/google-apps-script-google-drive 2025-03-08T12:56:18.017Z daily 0.8 https://aldosteroneyang.com/clinician-driven-automated-data-preprocessing-in-nuclear-medicine-ai-environments 2025-03-07T16:47:14.910Z daily 0.8 https://aldosteroneyang.com/article-review-clinician-driven-automated-data-preprocessing-in-nuclear-medicine-ai-environments 2025-03-07T16:47:14.298Z daily 0.8 https://aldosteroneyang.com/subendocardial-quantification-enhances-coronary-artery-disease-detection-in-18f-flurpiridaz-pet 2025-03-05T16:49:51.238Z daily 0.8 https://aldosteroneyang.com/article-review-subendocardial-quantification-enhances-coronary-artery-disease-detection-in-18f-flurpiridaz-pet 2025-03-05T16:49:50.885Z daily 0.8 https://aldosteroneyang.com/assessing-non-invasive-quantitative-methods-for-18f-synvest-1-pet-imaging-of-synaptic-vesicle-glycoprotein-2a-in-the-rat-brain 2025-03-04T16:49:59.745Z daily 0.8 https://aldosteroneyang.com/article-review-assessing-non-invasive-quantitative-methods-for-18f-synvest-1-pet-imaging-of-synaptic-vesicle-glycoprotein-2a-in-the-rat-brain 2025-03-04T16:49:59.075Z daily 0.8 https://aldosteroneyang.com/podcast-episode-346-hendrik-bessembinder-why-its-so-hard-to-beat-the-market-rational-reminder 2025-03-02T01:02:33.261Z daily 0.8 https://aldosteroneyang.com/correlation-of-early-phase-amyloid-positron-emission-tomography-and-neuropsychological-testing-in-patients-with-alzheimer-s-disease 2025-02-28T16:54:54.489Z daily 0.8 https://aldosteroneyang.com/article-review-correlation-of-early-phase-amyloid-positron-emission-tomography-and-neuropsychological-testing-in-patients-with-alzheimer-s-disease 2025-02-28T16:54:54.162Z daily 0.8 https://aldosteroneyang.com/exploring-the-landscape-of-current-in-vitro-and-in-vivo-models-and-their-relevance-for-targeted-radionuclide-theranostics 2025-02-28T16:54:07.561Z daily 0.8 https://aldosteroneyang.com/article-review-exploring-the-landscape-of-current-in-vitro-and-in-vivo-models-and-their-relevance-for-targeted-radionuclide-theranostics 2025-02-28T16:54:06.854Z daily 0.8 https://aldosteroneyang.com/improved-fapi-radiopharmaceutical-pharmacokinetics-from-the-perspectives-of-a-dose-escalation-study 2025-02-27T16:53:02.506Z daily 0.8 https://aldosteroneyang.com/article-review-improved-fapi-radiopharmaceutical-pharmacokinetics-from-the-perspectives-of-a-dose-escalation-study 2025-02-27T16:53:01.965Z daily 0.8 https://aldosteroneyang.com/3-year-overall-survival-benefit-of-systematic-follow-up-with-18f-fdg-pet-ct-in-asymptomatic-patients-treated-for-head-and-neck-squamous-cell-carcinoma-a-multicenter-study 2025-02-27T16:51:54.863Z daily 0.8 https://aldosteroneyang.com/article-review-3-year-overall-survival-benefit-of-systematic-follow-up-with-18f-fdg-pet-ct-in-asymptomatic-patients-treated-for-head-and-neck-squamous-cell-carcinoma-a-multicenter-study 2025-02-27T16:51:54.361Z daily 0.8 https://aldosteroneyang.com/deep-learning-image-enhancement-algorithms-in-pet-ct-imaging-a-phantom-and-sarcoma-patient-radiomic-evaluation 2025-02-27T16:51:13.150Z daily 0.8 https://aldosteroneyang.com/article-review-deep-learning-image-enhancement-algorithms-in-pet-ct-imaging-a-phantom-and-sarcoma-patient-radiomic-evaluation 2025-02-27T16:51:12.604Z daily 0.8 https://aldosteroneyang.com/recommendations-for-reporting-preclinical-radiobiological-studies-in-targeted-radionuclide-therapy 2025-02-27T16:50:21.526Z daily 0.8 https://aldosteroneyang.com/article-review-recommendations-for-reporting-preclinical-radiobiological-studies-in-targeted-radionuclide-therapy 2025-02-27T16:50:20.966Z daily 0.8 https://aldosteroneyang.com/clinical-benefits-of-lafov-pet-ct-in-growing-demand-for-molecular-imaging 2025-02-27T16:49:48.799Z daily 0.8 https://aldosteroneyang.com/article-review-clinical-benefits-of-lafov-pet-ct-in-growing-demand-for-molecular-imaging 2025-02-27T16:49:48.288Z daily 0.8 https://aldosteroneyang.com/external-validation-of-a-predictive-model-for-post-treatment-persistent-disease-by-131i-whole-body-scintigraphy-in-patients-with-differentiated-thyroid-cancer 2025-02-25T16:49:50.512Z daily 0.8 https://aldosteroneyang.com/article-review-external-validation-of-a-predictive-model-for-post-treatment-persistent-disease-by-131i-whole-body-scintigraphy-in-patients-with-differentiated-thyroid-cancer 2025-02-25T16:49:49.990Z daily 0.8 https://aldosteroneyang.com/weibull-distribution-overview 2025-02-24T02:21:49.883Z daily 0.8 https://aldosteroneyang.com/extreme-value-theory-evt-and-tail-related-risk-measures 2025-02-23T14:41:06.206Z daily 0.8 https://aldosteroneyang.com/podcast-episode-345-ama-3-rational-reminder 2025-02-23T01:42:03.402Z daily 0.8 https://aldosteroneyang.com/variable-transformation-evidential-method-vs-frequency-method 2025-02-22T12:23:37.406Z daily 0.8 https://aldosteroneyang.com/5yd5pw46l2j5ob77ya6k2j5poa5pa55rov6iih6ac7546h5pa55rov 2025-02-22T12:26:06.363Z daily 0.8 https://aldosteroneyang.com/the-promising-potential-of-camelid-nanobodies-for-nuclear-medicine 2025-02-21T16:49:43.667Z daily 0.8 https://aldosteroneyang.com/article-review-the-promising-potential-of-camelid-nanobodies-for-nuclear-medicine 2025-02-21T16:49:43.090Z daily 0.8 https://aldosteroneyang.com/artificial-intelligence-powered-coronary-artery-disease-diagnosis-from-spect-myocardial-perfusion-imaging-a-comprehensive-deep-learning-study 2025-02-20T16:50:11.467Z daily 0.8 https://aldosteroneyang.com/article-review-artificial-intelligence-powered-coronary-artery-disease-diagnosis-from-spect-myocardial-perfusion-imaging-a-comprehensive-deep-learning-study 2025-02-20T16:50:10.797Z daily 0.8 https://aldosteroneyang.com/podcast-episode-344-michael-mauboussin-the-one-job-of-an-equity-investor-rational-reminder 2025-02-20T02:00:18.237Z daily 0.8 https://aldosteroneyang.com/deep-learning-based-time-of-flight-tof-enhancement-of-non-tof-pet-scans-for-different-radiotracers 2025-02-18T16:51:25.946Z daily 0.8 https://aldosteroneyang.com/article-review-deep-learning-based-time-of-flight-tof-enhancement-of-non-tof-pet-scans-for-different-radiotracers 2025-02-18T16:51:25.135Z daily 0.8